Hypoactive Sexual Desire Disorder (HSDD) Treatment Market 2019-2027 – Credence Research | Industry Size, Share & Forecast

Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Is Expected To Expand At A CAGR of 5.2%

SAN JOSE, United States - August 14, 2019 /MarketersMedia/ —

The latest market report published by Credence Research, Inc. “Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market - Growth, Future Prospects, Competitive Analysis, 2019- 2027,” the global hypoactive sexual desire disorder (HSDD) treatment market is set to expand at a CAGR of 5.2% from 2019 to 2027.

Browse the full report Hypoactive Sexual Desire Disorder (HSDD) Treatment Market - Growth, Future Prospects, Competitive Analysis 2019 – 2027 at https://www.credenceresearch.com/report/hypoactive-sexual-desire-disorder-hsdd-treatment-market

Market Insights

Hypoactive sexual desire disorder (HSDD) is currently on a rise in adult women population manifested by low self confidence and less connected with their partners. Recent approval of Vyleesi will provide essential momentum for the HSDD market growth. Currently 2 drugs such as BP101 and Prasterone 6.5 mg vaginal insert are under phase 3 clinical trial are being investigated for its safety and efficacy for treatment of HSDD.

Hypoactive sexual desire disorder is the most common type of sexual dysfunction occurring in adult women worldwide manifested by lack of sex interest for a period of six months or more due to personal distress or fluctuating sex hormones during the menstrual cycle. Accurate diagnosis of the symptoms manifested in hypoactive sexual desire disorder (HSDD) is very critical to finalize the treatment regimen which is either psychotherapy or pharmacotherapy. The PLISSIT model (Permission, Limited Information, Specific Suggestions and Intensive Therapy) aids in initial screening of HSDD. Psychotherapy is suggested to patients showing positive response to counseling sessions with sex therapist.

Request Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Research Sample: https://www.credenceresearch.com/sample-request/59843

Pharmacotherapy comprises of buspirone and bupropion off label treatment for HSDD in women suffering with low libido associated with anxiety and depression. Testosterone transdermal patches are used as an off label treatment in premenopausal and postmenopausal women with HSDD. Flibanserin is currently the only drug approved by USFDA for treating HSDD in premenopausal women owing to its multifunctional serotonin agonist and antagonist pharmacodynamic profile.

North America is the largest regional segment in the hypoactive sexual desire disorder (HSDD) treatment market representing a market share of 38.5%. The chief attributing factors responsible for its supreme market growth are growing incidence of low libido in the female population owing to increasing stress in daily life and fluctuating sex hormones during the menstrual cycle. Domicile of key players such as AMAG Pharmaceutcials, Allergan, Plc., S1 Biopharma, Inc. and Sprout Pharmaceuticals, Inc. further propel the market growth in North America regional segment. Europe is placed in the second position with a market share of 32.4% primarily due to affordable reimbursement scenario for the medicines prescribed for the treatment of hypoactive sexual desire disorder (HSDD). Asia Pacific holding a market share of 15.2% will be growing at a rapid pace during the forecast period owing to rising prevalence of HSDD in working women population and developing healthcare infrastructure.

Pharmaceutical companies providing pharmacotherapy for treating hypoactive sexual desire disorder are AMAG Pharmaceutcials, Allergan, Plc., Ivix, LLX., EndoCeutics, Inc., Emotional Brain BV., S1 Biopharma, Inc. and Sprout Pharmaceutcials, Inc.

Key Market Movements:

Growing incidence of low sex drive in women population worldwide
Affordable reimbursement scenario for pharmacotherapy employed in the treatment of HSDD
Recent approval of Vyleesi and strong product pipeline will further propel the HSDD market growth during the forecast period

Request Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Research Sample: https://www.credenceresearch.com/sample-request/59843

TOC:

1. Preface...

2. Executive Summary...

3. Hypoactive Sexual Desire Disorder Treatment Market: Dynamics and Future Outlook...

Chapter 4. Global Hypoactive Sexual Desire Disorder Treatment Market, by Therapy
4.1. Overview
4.2. Buspirone
4.3. Bupropion
4.4. Testosterone
4.5. Flibanserin
4.6. Bremelanotide
4.7. Cognitive Behavior Therapy
4.8. Pipeline Analysis
4.8.1. Phase III Drug
4.8.1.1. Prasterone 6.5 mg Vaginal Insert
4.8.1.2. BP101

Chapter 5. Global Hypoactive Sexual Desire Disorder Treatment Market, by Geography
5.1. Overview
5.2. North America Hypoactive Sexual Desire Disorder Treatment Market Analysis, 2017 – 2027
5.2.1. North America Hypoactive Sexual Desire Disorder Treatment Market, by Therapy, 2017 – 2027 (US$ Mn)
5.2.2. North America Hypoactive Sexual Desire Disorder Treatment Market, by Country, 2017 – 2027 (US$ Mn)
5.2.2.1. U.S.
5.2.2.2. Canada
5.3. Europe Hypoactive Sexual Desire Disorder Treatment Market Analysis, 2017– 2027
5.3.1. Europe Hypoactive Sexual Desire Disorder Treatment Market, by Therapy, 2017 – 2027 (US$ Mn)
5.3.2. Europe Hypoactive Sexual Desire Disorder Treatment Market, by Country/Region, 2017 – 2027 (US$ Mn)
5.3.2.1. U.K.
5.3.2.2. Germany
5.3.2.3. Rest of Europe
5.4. Asia Pacific Hypoactive Sexual Desire Disorder Treatment Market Analysis, 2017 – 2027
5.4.1. Asia Pacific Hypoactive Sexual Desire Disorder Treatment Market, by Therapy, 2017 – 2027 (US$ Mn)
5.4.2. Asia Pacific Hypoactive Sexual Desire Disorder Treatment Market, by Country/Region, 2017 – 2027 (US$ Mn)
5.4.2.1. China
5.4.2.2. Japan
5.4.2.3. Rest of Asia Pacific...

Chapter 6. Company Profiles
6.1. AMAG Pharmaceuticals
6.1.1. Business Description
6.1.2. Financial Information (Subject to data availability)
6.1.3. Product Portfolio
6.1.4. News Coverage
6.2. Allergan, Plc.
6.3. Ivix LLX
6.4. EndoCeutics, Inc.
6.5. Emotional Brain BV ...

Browse the full report Hypoactive Sexual Desire Disorder (HSDD) Treatment Market - Growth, Future Prospects, Competitive Analysis 2019 – 2027 at https://www.credenceresearch.com/report/hypoactive-sexual-desire-disorder-hsdd-treatment-market

About Us:
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we've manufactured a firm extraordinarily prepared to this task.

Contact Info:
Name: Chris Smith
Email: Send Email
Organization: Credence Research
Address: 105 N 1st ST #429, SAN JOSE, CA 95103 US
Phone: +18003618290
Website: https://www.credenceresearch.com

Source URL: https://marketersmedia.com/hypoactive-sexual-desire-disorder-hsdd-treatment-market-2019-2027-credence-research-industry-size-share-forecast/88908175

Source: MarketersMedia

Release ID: 88908175

More News From Spotify News

LeBron posts latest triple-double, Lakers rally past Bulls

Dec 15, 2019

CHICAGO — LeBron James had 30 points, 11 assists and 10 rebounds for his third consecutive triple-double, and the Los Angeles Lakers rallied to beat the Chicago Bulls 118-112 on Tuesday night for their sixth straight victory. Los Angeles trailed by 19 before shutting down Chicago in the fourth quarter during the finale of a three-game trip. While James turned in another brilliant performance, he was on the bench for most of a 16-0 run to begin the final period. Kyle Kuzma, Quinn Cook and Dwight Howard sparked the Lakers' comeback. Kuzma scored 11 of his 15 points in the...

Antetokounmpo leads Bucks past Timberwolves 134-106

Dec 15, 2019

MINNEAPOLIS — The start to the game was unusual. Giannis Antetokounmpo's final stat line was not. After waiting out a long delay, Antetokounmpo had 34 points and 15 rebounds as the Milwaukee Bucks beat the Minnesota Timberwolves 134-106 on Monday night. Antetokounmpo, the reigning NBA MVP, has posted a double-double in all seven games this season. "Once you go out there, you have a mindset that you're going to play a game, you're going to go hard," Antetokounmpo said. "Once you cannot go hard, you've got to almost switch mindsets." The game was delayed 50 minutes so one of the...

Predators score 5 in second, beat Red Wings 6-1

Dec 15, 2019

DETROIT — Matt Duchene figured the Nashville Predators deserved better after scoring just once in a loss to the New York Rangers over the weekend. He had few complaints two nights later. Duchene scored two of Nashville's five second-period goals, and the Predators easily dispatched the Detroit Red Wings 6-1 on Monday night. One of Duchene's goals came when he flung the puck from along the boards near the blue line. It deflected in off the stick of Red Wings defenseman Madison Bowey. "I thought Saturday we did a lot of good things and probably should have scored that many...

Kane scores in overtime, Blackhawks beat Ducks 3-2

Dec 15, 2019

ANAHEIM, Calif. — Patrick Kane scored 24 second into overtime off a pass from Jonathan Toews and the Chicago Blackhawks beat the Anaheim Ducks 3-2 Sunday night. Rookie Adam Boqvist scored his first career NHL goal and Alex DeBrincat scored on a two-man advantage as the Blackhawks spoiled the 1,000th career game of Ducks center Ryan Getzlaf. Sam Steel and Nick Ritchie scored for Anaheim. Ryan Miller had 34 saves. Toews, stopped in traffic shortly after overtime began, spun around and slipped a cross-ice pass to Kane, who lifted the puck over the shoulder of Miller for the winner. Blackhawks...

Anthony Davis, LeBron James lead Lakers past Spurs

Dec 15, 2019

SAN ANTONIO — Anthony Davis had 25 points and 11 rebounds, LeBron James added 21 points, 13 assists and 11 rebounds and the Los Angeles Lakers held off the San Antonio Spurs 103-96 on Sunday night. James also had a triple-double Friday night in an overtime victory in Dallas. Dwight Howard had 14 points and 13 rebounds in a throw-back performance to help the Lakers improve to 5-1. Dejounte Murray had 18 points and 11 rebounds for the Spurs, Rudy Gay added 16 points off the bench, and DeMar DeRozan had 14. They lost for the second time in three...

About Us

Sportify News offers you high quality sports journalism. Take a deep look in the world of sports as we bring you the latest news on acquisitions, sponsorships, lineups and more!

Subscribe Now!